1. Academic Validation
  2. Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase

Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase

  • Biochem J. 1995 Jan 15;305 ( Pt 2)(Pt 2):479-84. doi: 10.1042/bj3050479.
J K Gierse 1 S D Hauser D P Creely C Koboldt S H Rangwala P C Isakson K Seibert
Affiliations

Affiliation

  • 1 Searle Inflammatory Disease Research, Monsanto Company, St. Louis, MO 63167.
Abstract

The Enzyme cyclo-oxygenase catalyses the oxygenation of arachidonic acid, leading to the formation of prostaglandins. Recently two forms of cyclo-oxygenase have been described: a constitutive (COX-1) Enzyme present in most cells and tissues, and an inducible (COX-2) isoenzyme observed in many cells in response to pro-inflammatory cytokines. Constitutive and inducible forms of human cyclo-oxygenase (hCOX-1 and hCOX-2) were cloned and expressed in insect cells, utilizing a baculovirus expression system. hCOX-1 had a specific activity of 18.8 mumol of O2/mg with a Km of 13.8 microM for arachidonate and Vmax. of 1500 nmol of O2/nmol of Enzyme, whereas hCOX-2 had a specific activity of 12.2 mumol of O2/mg with a Km of 8.7 microM for arachidonate and a Vmax. of 1090 nmol of O2/nmol of Enzyme. Indomethacin inhibited both hCOX-1 and hCOX-2, whereas NS-398 and Dup-697 selectively inhibited hCOX-2. Both NS-398 and Dup-697 exhibited time-dependent inactivation of hCOX-2, as did indomethacin on both Enzymes. The competitive inhibitor of hCOX-1, mefenamic acid, also displayed competitive inhibition of hCOX-2. These results demonstrate the ability to generate selective non-steroidal anti-inflammatory drugs (NSAIDs), which could provide useful improvement therapeutically in the treatment of chronic inflammatory disease.

Figures
Products